Industry Bulletins | June 15, 2021
Monogram Health Closes $160 Million Series B Funding To Fuel Acceleration Of Next Generation Kidney Care Model
Monogram Health, a benefit management and care delivery company transforming care for individuals with chronic kidney and end-stage renal disease, announced that it has closed a $160 million Series B funding round led by TPG Capital, the private equity platform of global alternative asset firm TPG. The funding round also includes existing investors Frist Cressey Ventures and Norwest Venture Partners, as well as Humana Inc. and other notable national and regional strategic investors.
The investment will be used to fuel the company’s continued rapid expansion as the leading solution for improved kidney care in the U.S. In . . .